Consistently, our in vivo study in a TP53-mutated oral cancer-xenograft mouse model showed that PEITC at 5 or 10 mg per kg body weight can slow down tumor growth and prolong the survival of cancer-bearing mice along with increased p53 expression in the nucleus of tumor cells in the tissue [9]. Here, TP53 is linked to lip and oral cavity carcinoma.